Adult Obesity Facts, CDC Liraglutide 3.0 mg and Intensive Behavioral Therapy (IBT) for Obesity in Primary Care: The SCALE IBT Randomized Controlled Trial, Obesity (2020) Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity, The New England Journal of Medicine (2023) GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects, Frontiers in Endocrinology (2021) Wegovy: Understanding list price, NovoCare How much should I expect to pay for Mounjaro?, Lilly (2023) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Gastrointestinal adverse effects represent the most common tolerability concerns with GLP-1 receptor agonists, occurring in 2050% of patients
See the comparison table for the full side-by-side
Recently, some patients have reported stomach paralysis, which can lead to excessive vomiting and suicidal thoughts
This is a shift from earlier watchful waiting approaches
Peptide Therapy Your body naturally makes peptides that support your health and healing processes